Does RAVULIZUMAB-CWVZ Cause Myasthenia gravis? 338 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 338 reports of Myasthenia gravis have been filed in association with RAVULIZUMAB-CWVZ. This represents 3.3% of all adverse event reports for RAVULIZUMAB-CWVZ.
338
Reports of Myasthenia gravis with RAVULIZUMAB-CWVZ
3.3%
of all RAVULIZUMAB-CWVZ reports
8
Deaths
139
Hospitalizations
How Dangerous Is Myasthenia gravis From RAVULIZUMAB-CWVZ?
Of the 338 reports, 8 (2.4%) resulted in death, 139 (41.1%) required hospitalization, and 4 (1.2%) were considered life-threatening.
Is Myasthenia gravis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 338 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Back pain (326)
What Other Drugs Cause Myasthenia gravis?
EFGARTIGIMOD ALFA-FCAB (691)
ECULIZUMAB (487)
PEMBROLIZUMAB (469)
NIVOLUMAB (451)
PREDNISONE (217)
IPILIMUMAB (201)
PYRIDOSTIGMINE (193)
HUMAN IMMUNOGLOBULIN G (186)
ZILUCOPLAN (184)
GABAPENTIN (172)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Myasthenia gravis Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST